Placebo analgesia and social learning: Is it possible to increase medication effect via processes of social learning?

Not Applicable

• Conditions: M54; Dorsalgia

• Registration Number: DRKS00011230
• Lead Sponsor: niversitätsklinikum Hamburg-Eppendorf (UKE)?Zentrum für Anästhesiologie und Intensivmedizin?Klinik und Poliklinik für Anästhesiologie?Bereich Schmerzmedizin und Schmerzpsychologie?

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-11-29
• Study Completion: 2018-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

Patients with chronic back pain, ongoing treatment in the pain center of the UKE, ongoing medication: Amitriptyline.

Exclusion Criteria

acute or chronic mentally disorders excluding: F45.41 (nach ICD-10; DSM-IV bzw. DSM-V), insufficient knowledge of German language or eye-sight, cognitive impairment or intake of medication, which impairs consciousness.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain rating: Numerical Rating Scale (NRS) 0-10, Pre-, Post-, 2 weeks follow up

Secondary Outcome Measures

Name	Time	Method
pain associated variables: <br>Pain Disability, functional capacity, depressive mood, pain catastrophizing, quality of life<br><br>Pre, post, 2 weeks follow up (concerning experimental social learning situation)